Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.